首页|基于网络药理学探讨丹参治疗类风湿关节炎的潜在分子机制

基于网络药理学探讨丹参治疗类风湿关节炎的潜在分子机制

扫码查看
目的 基于网络药理学探讨丹参治疗类风湿关节炎的分子机制。方法 利用中药系统药理数据库与分析平台(TCMSP)获取丹参的活性成分及靶点,与GeneCards、OMIM数据库获取的类风湿关节炎疾病基因靶点映射,构建药物-活性成分-疾病靶点网络。DAVID数据库中进行基因本体论(GO)功能富集和京都基因和基因组百科全书(KEGG)通路富集分析。结果 从丹参中筛选到 56 种活性成分,作用靶点基因 100 个;检索类风湿关节炎疾病靶点基因 1640 个;取丹参与类风湿关节炎疾病靶点基因交集共得到 44 个共同靶点,其中 13 个为关键靶点。获得 96 条GO生物学过程和 25 条KEGG信号通路,涉及免疫调节、炎症反应及细胞凋亡等。结论 丹参可能通过多成分、多靶点网络来治疗类风湿关节炎。
Exploration of the potential molecular mechanisms of Salvia Miltiorrhiza in treating rheumatoid arthritis based on network pharmacology
Objective To explore the potential molecular mechanisms of Salvia Miltiorrhiza in treating rheumatoid arthritis based on network pharmacology.Methods The traditional Chinese medicine systems pharmacology database and analysis platform(TCMSP)was used to obtain the active ingredients and targets of Salvia Miltiorrhiza,which were mapped with the rheumatoid arthritis disease gene targets obtained from GeneCards and OMIM databases,to construct a drug-active ingredient-disease target network.Gene ontology(GO)functional enrichment,and Kyoto encyclopedia of genes and genomes(KEGG)pathway enrichment analysis were performed in the DAVID database.Results A total of 56 active ingredients and 100 target genes were screened from Salvia Miltiorrhiza.A total of 1640 target genes for rheumatoid arthritis disease were retrieved.A total of 44 common targets were obtained from the intersection of Salvia Miltiorrhiza and rheumatoid arthritis disease target genes,of which 13 were key targets.A total of 96 GO biological processes and 25 KEGG signaling pathways were obtained,involving immune regulation,inflammatory response,and apoptosis.Conclusion Salvia Miltiorrhiza can be used to treat rheumatoid arthritis through a multi-component and multi-target network.

Network pharmacologySalvia MiltiorrhizaRheumatoid arthritisMolecular mechanism

李自霖、王桂花、张翠香、陈贵元、李雪英

展开 >

大理大学基础医学院生物化学与分子生物学教研室,云南大理 671000

大理大学第一附属医院呼吸与危重症医学科,云南大理 671000

网络药理学 丹参 类风湿关节炎 分子机制

2024

中国医药科学
海峡两岸医药卫生交流协会 二十一世纪联合创新(北京)医药科学研究院

中国医药科学

影响因子:1.083
ISSN:2095-0616
年,卷(期):2024.14(9)